New Year, New Us: Get A Sneak Peak At Our New Site

Ask the Oncologist

  1. Does the presence of preexisting CVD affect your decision making for prostate cancer treatment?
  2. When do you involve a cardiologist or cardio-oncologist for CV risk assessment?
  3. What are your expectations as an oncologist when you request a CV evaluation?
  4. What do you need to know before starting treatment?
  5. How will the results of PRONOUNCE trial affect your clinical decision making for prostate cancer treatment?

Cardiovascular Morbidity in a Randomized Trial

2019 – CV morbidity
RCT comparing GnRH agonist and GnRH antagonist

May 2020 ICOS Monthly Journal Club

Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
Dr. Courtney Campbell, The Ohio State University